• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WU You, TANG Tingting, ZHU Qinhua, JIN Liang, PAN Yi. Mechanisms of miR-29a in migration and invasion of breast cancer MCF-7 cells in vitro[J]. Journal of China Pharmaceutical University, 2018, 49(3): 348-353. DOI: 10.11665/j.issn.1000-5048.20180314
Citation: WU You, TANG Tingting, ZHU Qinhua, JIN Liang, PAN Yi. Mechanisms of miR-29a in migration and invasion of breast cancer MCF-7 cells in vitro[J]. Journal of China Pharmaceutical University, 2018, 49(3): 348-353. DOI: 10.11665/j.issn.1000-5048.20180314

Mechanisms of miR-29a in migration and invasion of breast cancer MCF-7 cells in vitro

More Information
  • The aim of this study was to investigate the effect and mechanisms of miR-29a in migration and invasion of human breast cancer MCF-7 cells in vitro. MCF-7 cells were treated with miR-29a mimic or miR-29a inhibitor to up-regulate/down-regulate the expression level of miR-29a. Wound-healing assay and transwell chamber were employed to determine cell migration and invasion in vitro. The target gene of miR-29a was predicted with the Targetscan7. 1 database and verified through luciferase reporter method. The effects of miR-29a on the expression of the potential target were detected by Western blot and real-time PCR. Results showed that in vitro migration and invasion ability of MCF-7 cells was increased significantly by miR-29a, which could target HBP1 in the 3′-UTR region. The protein expression of HBP1 was decreased by miR-29a overexpression. However, the alteration of miR-29a had no significant effect on the expression of HBP1 mRNA. The results validated that miR-29a, highly expressed in breast cancer, could down-regulate HBP1, which in turn promotes migration and invasion ability of breast cancer cells, thus promoting breast cancer metastasis.
  • [1]
    Redig AJ,McAllister SS.Breast cancer as a systemic disease:a view of metastasis[J].J Intern Med,2013,274(2):113-126.
    [2]
    Zhang K,Zhang Y,Liu C,et al.MicroRNAs in the diagnosis and prognosis of breast cancer and their therapeutic potential[J].Int J Oncol,2014,45(3):950-958.
    [3]
    Di Leva G,Garofalo M,Croce CM.microRNAs in cancer[J].Annu Rev Pathol,2014,9:287-314.
    [4]
    Pei YF,Lei Y,Liu XQ.MiR-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1[J].Biochim Biophys Acta,2016,1862(11):2177-2185.
    [5]
    Rostas JW,Pruitt HC,Metge BJ,et al.microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer[J].Mol Cancer,2014,13:200.
    [6]
    Shukla GC,Singh J,Barik S.MicroRNAs:processing,maturation,target recognition and regulatory functions[J].Mol Cell Pharmacol,2011,3(3):83-92.
    [7]
    Debacker K,Kooy RF.Fragile sites and human disease[J].Hum Mol Genet,2007,16(2):150-158.
    [8]
    Chen L,Xiao H,Wang ZH,et al.miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A[J].BMB Rep,2014,47(1):39-44.
    [9]
    Tréhoux S,Lahdaoui F,Delpu Y,et al.Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells[J].Biochim Biophys Acta,2015,1853(10 Pt A):2392-2403.
    [10]
    Yamamoto N,Kinoshita T,Nohata N,et al.Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma[J].Int J Oncol,2013,43(6):1855-1863.
    [11]
    Pasqualini L,Bu H,Puhr M,et al.miR-22 and miR-29a are members of the androgen receptor cistrome modulating LAMC1 and Mcl-1 in prostate cancer[J].Mol Endocrinol,2015,29(7):1037-1054.
    [12]
    Liu C,Duan P,Li B,et al.miR-29a activates Hes1 by targeting Nfia in esophageal carcinoma cell line TE-1[J].Oncol Lett,2015,9(1):96-102.
    [13]
    Tang W,Zhu Y,Gao J,et al.MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4[J].Br J Cancer,2014,110(2):450-458.
    [14]
    Shih HH,Xiu M,Berasi SP,et al.HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue[J].Mol Cell Biol,2001,21(17):5723-5732.
    [15]
    Huang JS, Xiao R, Pang Y, et al. HBP1—an important tumor inhibitor[J].Chin J Biochem Mol Biol(中国生物化学与分子生物学报),2012,28(10):913-918.
    [16]
    Paulson KE,Rieger-Christ K,McDevitt MA,et al.Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer[J].Cancer Res,2007,67(13):6136-6145.
    [17]
    Yee AS,Paulson EK,McDevitt MA,et al.The HBP1 transcriptional repressor and the p38 MAP kinase:unlikely partners in G1 regulation and tumor suppression[J].Gene,2004,336(1):1-13.
    [18]
    Sampson EM,Haque ZK,Ku MC,et al.Negative regulation of the Wnt/b-catenin pathway by the transcriptional repressor HBP1[J].EMBO J,2001,20(16):4500-4511.
    [19]
    Qin X,Zhang H,Zhou X,et al.Proliferation and migration mediated by Dkk-1/Wnt/b-catenin cascade in a model of hepatocellular carcinoma cells[J].Transl Res,2007,150(5):281-294.
    [20]
    Wang Z,Ma Q.Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer[J].Med Hypotheses,2007,69(4):816-820.
  • Related Articles

    [1]SHI Wenxing, LYU Qing, QU Guiwu, ZHAO Ying, ZHOU Fengmei. Therapeutic effect and mechanism of sodium formononetin-3′-sulphonate on collagen-induced rheumatoid arthritis[J]. Journal of China Pharmaceutical University, 2021, 52(5): 579-585. DOI: 10.11665/j.issn.1000-5048.20210510
    [2]LIN Xiaobing, WANG Hao, ZHANG Junhan, LIN Zihao, YAN Ming, AN Xiaofei. Screening of prostaglandin E2 receptor 4 antagonist from active compounds of Baeckea frutescens L. and its anti-rheumatoid arthritis effect in vivo[J]. Journal of China Pharmaceutical University, 2021, 52(1): 92-99. DOI: 10.11665/j.issn.1000-5048.20210113
    [3]ZHANG Ting, LIAO Hang, CHENG Yuting, WU Xiaohong. Preparation and properties of injectable minocycline hydrochloride microsphere depot[J]. Journal of China Pharmaceutical University, 2021, 52(1): 52-59. DOI: 10.11665/j.issn.1000-5048.20210107
    [4]LIU Bowen, LIU Fulei, WANG Ruyi, XUE Jingwei, LIU Wenyuan, FENG Feng, QU Wei. Chemical constituents of total alkaloids from Picrasma quassioides and its effects on collagen induced arthritis in rats[J]. Journal of China Pharmaceutical University, 2019, 50(5): 585-592. DOI: 10.11665/j.issn.1000-5048.20190512
    [5]WANG Chen, HUANG Xin, JIANG Zhenzhou, ZHANG Luyong. Advances in the role of steroids in rheumatoid arthritis[J]. Journal of China Pharmaceutical University, 2015, 46(6): 757-763. DOI: 10.11665/j.issn.1000-5048.20150621
    [6]WU Qi, WU Qian, LUO Xun. Effects of Cynanchum paniculatum paeonol on apoptosis of articular chondrocyte in rabbits with knee osteoarthritis[J]. Journal of China Pharmaceutical University, 2015, 46(3): 359-363. DOI: 10.11665/j.issn.1000-5048.20150317
    [7]LI Pei, WANG Da-wei, LIU Xiao-dong. Tumor necrosis factor-αand its receptors in rheumatoid arthritis[J]. Journal of China Pharmaceutical University, 2011, 42(3): 276-283.
    [8]JING Li-juan, WANG Mei-mei. Relationship between RANKL/OPG system and typeⅡcollagen-induced arthritis in rats and the intervention of [99Tc]-methylene diphosphonate[J]. Journal of China Pharmaceutical University, 2011, 42(3): 251-254.
    [10]Effect of Tripterygium wilfordii PAP Patcher(TWPP) on Adjuvant Arthritis in Rats[J]. Journal of China Pharmaceutical University, 1995, (4): 223-225.
  • Cited by

    Periodical cited type(3)

    1. 杜泽飞,张国文,孙健玮. 重楼中皂苷类成分抗肿瘤作用及机制研究进展. 云南医药. 2024(02): 73-75 .
    2. 刘天会. 细胞器之间相互作用在非酒精性脂肪性肝病发生发展中的作用. 临床肝胆病杂志. 2023(01): 181-187 .
    3. 曹守莹. 新型吡啶氮唑氮芥化合物与线粒体的作用及其抗肿瘤活性. 湖北理工学院学报. 2021(01): 56-61 .

    Other cited types(6)

Catalog

    Article views (832) PDF downloads (1100) Cited by(9)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return